On 3 December 2025, Judy Kingswolf-Yamakawa attended Certara’s Biotech Forum, an exclusive workshop designed for biotech executives, founders, and investors. The event provided invaluable insights on strengthening development strategies, improving the chances of successful therapy commercialization, and avoiding common early-stage pitfalls. Judy had the opportunity to learn from a distinguished group of speakers, including Matthias Breugelmans (Mundipharma), Marc Daigneault (Medicines Discovery Catapult), and Ian Wilson (ex-CEO, ImaginAb), who shared their expertise on de-risking biotech development and the crucial steps to align science, regulatory pathways, and commercial strategy. The session fostered great cooperation among attendees, with expert-led discussions on everything from identifying the right clinical candidate to navigating funding and investor concerns. Judy engaged in dynamic conversations with fellow leaders and specialists, gaining practical advice and forward-thinking strategies that will aid in shaping the future of biotech innovation.